1. The heterogeneity of cancer

   • H. Gilbert Welch

   Editorial 02 February 2018 Pages: 207 - 208

2. Chronic postsurgical pain following breast reconstruction: a commentary and critique

   • Randy S. Roth

   Review 30 January 2018 Pages: 209 - 216

3. Rapid review: radiomics and breast cancer

   • Francesca Valdora
   • Nehmat Houssami
   • Alberto Stefano Tagliafico

   Review 02 February 2018 Pages: 217 - 229

4. The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

   • Sara Jansson
   • Kristina Aaltonen
   • Lisa Rydén

   Preclinical study Open access 29 January 2018 Pages: 231 - 241

   

5. Machine learning to parse breast pathology reports in Chinese

   • Rong Tang
   • Lizhi Ouyang
   • Kevin Hughes

   Preclinical study 29 January 2018 Pages: 243 - 250

   

6. Lymph drainage of the upper limb and mammary region to the axilla: anatomical study in stillborns

   • Guilherme de Arruda Cuadrado
   • Mauro Figueiredo Carvalho de Andrade
   • Alfredo Luiz Jacomo

   Preclinical study 29 January 2018 Pages: 251 - 256

   

7. A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer

   • Sae Byul Lee
   • Guiyun Sohn
   • Sei-Hyun Ahn

   Preclinical study Open access 31 January 2018 Pages: 257 - 266

   

8. Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes

   • Shunheng Zhou
   • Lihong Wang
   • Wei Jiang

   Preclinical study 01 February 2018 Pages: 267 - 275

   

9. Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

   • Nouf Al-Subhi
   • Reem Ali
   • Srinivasan Madhusudan

   Preclinical study Open access 02 February 2018 Pages: 277 - 286

   

10. Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare Registry

    • Mark Fairweather
    • Wei Jiang
    • Faina Nakhlis

    Clinical trial 27 January 2018 Pages: 287 - 293

11. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma

    • Anne-Sophie Hamy
    • Giang-Thanh Lam
    • Fabien Reyal

    Clinical study 27 January 2018 Pages: 295 - 304

    

12. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow

    • Vincent P. Walter
    • Florin-Andrei Taran
    • Andreas D. Hartkopf

    Clinical trial 27 January 2018 Pages: 305 - 309

    

13. Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database

    • Ki-Tae Hwang
    • Eun-Kyu Kim
    • Korean Breast Cancer Society

    Clinical trial 30 January 2018 Pages: 311 - 322

    

14. The frequency of missed breast cancers in women participating in a high-risk MRI screening program

    • S. Vreemann
    • A. Gubern-Merida
    • R. M. Mann

    Clinical trial Open access 31 January 2018 Pages: 323 - 331

    

15. Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer

    • Julia Foldi
    • Sarah Mougalian
    • Lajos Pusztai

    Clinical trial 02 February 2018 Pages: 333 - 340

    

16. Cross-reactivity between MUC1 antigen and MCA: false elevation of serum CA 15-3 level in pregnant and lactating women by Ma695–Ma552-based assay

    • Guangshu Liang
    • Xuqian Fang
    • Zhidong Gu

    Clinical trial 02 February 2018 Pages: 341 - 347

    

17. Complications following immediate compared to delayed deep inferior epigastric artery perforator flap breast reconstructions

    • J. Beugels
    • L. Bod
    • R. R. W. J. van der Hulst

    Clinical trial Open access 05 February 2018 Pages: 349 - 357

18. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

    • E. Rakovitch
    • R. Gray
    • L. J. Solin

    Epidemiology Open access 31 January 2018 Pages: 359 - 369

    

19. A comprehensive tool for measuring mammographic density changes over time

    • Mikael Eriksson
    • Jingmei Li
    • Per Hall

    Epidemiology Open access 01 February 2018 Pages: 371 - 379

    

20. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer

    • Margarite D. Matossian
    • Hope E. Burks
    • Bridgette M. Collins-Burow

    Brief Report 01 February 2018 Pages: 381 - 390

    

21. Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

    • Nicholas B. Figura
    • Wendy Long
    • Kamran A. Ahmed

    Brief Report 01 February 2018 Pages: 391 - 396